Pharmalot.. Pharmalittle.. Good Morning.. Catching up on Pfizer, Valeant, Shkreli and..
Hello, everyone, and how are you today? We are just fine, thank you. Our outlook is brightened by the delightful combination of a shiny sun enveloping the leafy Pharmalot campus and a few cups of stimulation, which are as needed as ever. Feel free to join us. Remember, no prescription is required. And now, time to get cracking. We trust that you can relate. So here are a few items of interest to help you along. Have a great day and keep in touch…
Pfizer is increasing its financial assistance to patients, doubling the allowable income level for people to receive dozens of its medicines for free; What does Martin Shkreli think of the US Senators investigating pricing practices at his company? “The senators have their facts wrong,” he says; Gilead Sciences’ blockbuster hepatitis C medicine Sovaldi may trigger an abnormally slow heartbeat and put patients at risk of passing out; and Roche’s Kadcyla, an expensive breast cancer drug, will remain on the list of medicines available on the UK’s National Health Service after the drug maker agreed to lower the price.